Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Advancing a sustainable supply and demand ecosystem for monoclonal antibodies in Africa

On April 6, 2025, Africa CDC and IAVI, with support from Wellcome and Unitaid, convened a high-level meeting in Abu Dhabi to chart a pathway for advancing a sustainable mAb ecosystem in Africa. The consensus was clear: Africa has the opportunity and capacity to leapfrog and lead in mAbs innovation and production.

Read more

In The News

Enhancing Lassa Fever Medical Countermeasures in West Africa

Nigeria Health Watch

September 24, 2025

Read more

In The News

Voices From #ELFIC2025 | Dr. Mark Feinberg, President & CEO, International AIDS Vaccine Initiative

Nigeria Health Watch

September 18, 2025

Read more

In The News

CHOP’s Vaccine Education Center experts fear policy changes coming under RFK’s health leadership

The Philadelphia Inquirer

September 18, 2025

Read more

About IAVI’s Lassa virus vaccine program

IAVI and our partners are developing a single-dose vaccine candidate for protection against Lassa virus (LASV). No vaccine is yet approved to prevent Lassa fever, the illness caused by LASV.

Read more

About IAVI’s Marburg virus vaccine program

IAVI is developing a vaccine candidate for protection against Marburg virus (MARV), a deadly pathogen and potential bioweapon that repeatedly causes severe outbreaks.

Read more

About IAVI’s Sudan virus vaccine program

IAVI is developing a vaccine candidate for protection against Sudan virus (SUDV) and has contributed to outbreak responses in sub-Saharan Africa. 

Read more

Features

Fast facts about IAVI’s contributions to fighting Lassa fever in West Africa

September 11, 2025

IAVI has been developing emerging infectious disease (EID) vaccines for a range of priority pathogens, including Lassa virus, since 2018.

Read more